AXLA Projected Dividend Yield
Axcella Health Inc ( OTCBB : AXLA )Axcella Health is a clinical-stage biotechnology company focused on an approach to treat diseases using compositions of endogenous metabolic modulators. Co.'s pipeline includes main therapeutic candidates for the treatment of Long COVID associated fatigue, and for the treatment of non-alcoholic steatohepatitis (NASH). AXA1125 is being developed as a product candidate for the treatment of Long COVID. AXA1125 is an oral product candidate for the treatment of NASH. AXA1665 is a product candidate for the reduction in risk of Overt Hepatic Encephalopathy recurrence in adult patients with liver cirrhosis. 20 YEAR PERFORMANCE RESULTS |
AXLA Dividend History Detail AXLA Dividend News AXLA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |